Showing results (101-110 of 125) with videos related to
Sort By:
Pageof 13
Progress in Clinical and Biological Research|January 1, 1982
Influence of quantity of granulocytes transfused on responseE F Winton, S Moffitt, W R Vogler, et al.The Journal of Biological Chemistry|April 22, 1994
Human leukemia K562 cell mutant (K562/OA200) selected for resistance to okadaic acid (protein phosphatase inhibitor) lacks protein kinase C-epsilon, exhibits multidrug resistance phenotype, and expresses drug pump P-glycoproteinB Zheng, T C Chambers, R L Raynor, et al.Leukemia Research|March 1, 1994
Effect of herbimycin A, an inhibitor of tyrosine kinase, on protein tyrosine kinase activity and phosphotyrosyl proteins of Ph1-positive leukemia cellsM Okabe, K Kawamura, T Miyagishima, et al.Leukemia|October 1, 1992
Phase II clinical trial of carboplatin in relapsed and refractory leukemiaW R Vogler, D P Harrington, E F Winton, et al.Bone Marrow Transplantation|December 1, 1990
Ophthalmological and other toxicities related to cytosine arabinoside and total body irradiation as preparative regimen for bone marrow transplantationW R Vogler, E F Winton, L T Heffner, et al.Anticancer Research|November 1, 1987
Lack of correlation between cytotoxicity of agonists and antagonists of platelet activating factor [paf-acether] in neoplastic cells and modulation of [3H]-paf-acether binding to platelets from humans in vitroW E Berdel, R Korth, A Reichert, et al.Leukemia Research|October 1, 1992
Use of the polymerase chain reaction to detect hypermethylation in the calcitonin gene. A new, sensitive approach to monitor tumor cells in acute myelogenous leukemiaT Fukuhara, W C Hooper, S B Baylin, et al.Experimental Hematology|May 1, 1989
Therapeutic activity of 1-beta-D-arabinofuranosylcytosine conjugates of lipids in WEHI-3B leukemia in miceW E Berdel, S Okamoto, S Danhauser-Riedl, et al.Blood|November 1, 1988
Leukemia of non-T lineage natural killer cellsW Sheridan, E F Winton, W C Chan, et al.Leukemia & Lymphoma|January 1, 1996
High dose cyclophosphamide, fractionated total body irradiation with involved field irradiation and autologous bone marrow transplantation in malignant lymphomaM R Tirona, D S Gordon, I Crocker, et al.Pageof 13